Telemus Capital’s ResMed RMD Stock Holding History

Telemus Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-450	Closed	-$38K	–	524
2017 Q4	$38K	Buy	+450	New	+$37.2K	﹤0.01%	435

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Telemus Capital's RMD Position: Q1 2018 in Review

Telemus Capital sold out of ResMed (RMD) in Q1 2018, closing a stake of 450 shares — an estimated $38K sold.

Telemus Capital first reported a position in RMD in Q4 2017 and held it in 1 quarter. The position peaked at $38K in Q4 2017. 445 funds tracked by Wall St. Rank hold RMD as of Q1 2018.

Telemus Capital reported no remaining ResMed position as of Q1 2018 after selling out during the quarter.
Telemus Capital sold 450 ResMed shares in Q1 2018, an estimated $38K.
Telemus Capital first reported a position in ResMed in Q4 2017 and held it in 1 quarter.
Telemus Capital's ResMed position peaked at $38K in Q4 2017.
445 funds tracked by Wall St. Rank held ResMed as of Q1 2018.

Based on Telemus Capital's 13F filing for Q1 2018, filed 27 Apr 2018.